nach oben

Clinical Orthopaedics and Related Research®

Erschienen in:

01.07.2013 | Basic Research

Isoniazid Could Be Used for Antibiotic-loaded Bone Cement for Musculoskeletal Tuberculosis: An In Vitro Study

verfasst von: Chang Dong Han, MD, PhD, Taegwon Oh, RPH, PhD, Sang-Nae Cho, DVM, PhD, Jae Ho Yang, MD, Kwan Kyu Park, MD, PhD

Erschienen in: Clinical Orthopaedics and Related Research® | Ausgabe 7/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Antibiotic-loaded bone cement (ALBC) has been used in serious cases of musculoskeletal tuberculosis, but the type and amount of antibiotic that should be used in ALBC have not been determined.

Questions/purposes

We therefore determined the (1) elution characteristics and (2) antimycobacterial activity of isoniazid- and rifampicin-loaded bone cement.

Methods

A total of 240 elution samples of each of three discs from 40 g bone cement mixed with one of eight dosages: 1 g, 2 g, and 4 g isoniazid, 1 g, 2 g, and 4 g rifampicin, and a combination of 1 + 1 g or 2 + 2 g of isoniazid and rifampicin. The polymerization of rifampicin-loaded bone cement was delayed to mean 122.5 ± 31.1 minutes. We measured the quantity of isoniazid and rifampicin and the antimycobacterial activity on Days 1, 3, 7, 14, and 30.

Results

Isoniazid eluted in almost all the samples while rifampicin was detected only on Day 1 with 2 g (0.7 ± 0.4 ug/mL/day), and until Day 14 with 4 g (0.1 ± 0.0u g/mL/day). Most of the samples containing isoniazid showed antimycobacterial activity while the samples containing rifampicin showed antimycobacterial activity only on Day 1 with 1 g (0.52 ± 0.18 ug/mL), until Day 14 with 2 g (0.03 ± 0.00 ug/mL), and until Day 30 with 4 g (1.84 ± 1.90 ug/mL).

Conclusion

Rifampicin was unsuitable for ALBC because of its delayed polymerization. Isoniazid eluted and showed antimycobacterial activity for 30 days.

Clinical Relevance

The data suggest isoniazid could be considered for use in ALBC for musculoskeletal tuberculosis if used with systemic treatment. For preventing resistance and systemic toxicity, a combination with a second-line drug and an in vivo study would be needed.

Anguita-Alonso P, Rouse MS, Piper KE, Jacofsky DJ, Osmon DR, Patel R. Comparative study of antimicrobial release kinetics from polymethylmethacrylate. Clin Orthop Relat Res. 2006;445:239–244.PubMed

Beeching NJ, Thomas MG, Roberts S, Lang SD. Comparative in-vitro activity of antibiotics incorporated in acrylic bone cement. J Antimicrob Chemother. 1986;17:173–184.PubMedCrossRef

Bennett WM, Singer I, Golper T, Feig P, Coggins CJ. Guidelines for drug therapy in renal failure. Ann Intern Med. 1977;86:754–783.PubMedCrossRef

Biron F. [Resection of the knee joint][in German]. Z Orthop Ihre Grenzgeb. 1965;100:221–225.PubMed

Bridgens J, Davies S, Tilley L, Norman P, Stockley I. Orthopaedic bone cement: do we know what we are using? J Bone Joint Surg Br. 2008;90:643–647.PubMed

Bryan WJ, Doherty JH Jr, Sculco TP. Tuberculosis in a rheumatoid patient: a case report. Clin Orthop Relat Res. 1982;171:206–208.PubMed

Buchholz HW, Engelbrecht H. [Depot effects of various antibiotics mixed with Palacos resins][in German]. Chirurg. 1970;41:511–515.PubMed

Campos OP. Bone and joint tuberculosis and its treatment. J Bone Joint Surg Am. 1955;37:937–966.PubMed

Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises: Case 43-1983. An elderly man with progressive pain and swelling of the knee. N Engl J Med. 1983;309:1042–1049.

10.

Changsen C, Franzblau SG, Palittapongarnpim P. Improved green fluorescent protein reporter gene-based microplate screening for antituberculosis compounds by utilizing an acetamidase promoter. Antimicrob Agents Chemother. 2003;47:3682–3687.PubMedCrossRef

11.

Chohfi M, Langlais F, Fourastier J, Minet J, Thomazeau H, Cormier M. Pharmacokinetics, uses, and limitations of vancomycin-loaded bone cement. Int Orthop. 1998;22:171–177.PubMedCrossRef

12.

Collins LA, Torrero MN, Franzblau SG. Green fluorescent protein reporter microplate assay for high-throughput screening of compounds against Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1998;42:344–347.PubMed

13.

De Palma L, Greco F, Ciarpaglini C, Caneva C. The mechanical properties of “cement-antibiotic” mixtures. Ital J Orthop Traumatol. 1982;8:461–467.PubMed

14.

Dhillon J, Mitchison DA. Activity and penetration of antituberculosis drugs in mouse peritoneal macrophages infected with Mycobacterium microti OV254. Antimicrob Agents Chemother. 1989;33:1255–1259.PubMedCrossRef

15.

Fowler GR. Is resection of the knee-joint justifiable in children? Ann Surg. 1889;9:439–445.PubMedCrossRef

16.

Galasso O, Mariconda M, Calonego G, Gasparini G. Physical, mechanical and pharmacological properties of coloured bone cement with and without antibiotics. J Bone Joint Surg Br. 2011;93:1529–1536.PubMed

17.

Gelikonova VS. [Conservative resection of the knee joint in the treatment of tuberculous gonitis in children as seen in the light of remote results][in Russian]. Ortop Travmatol Protez. 1957;18:38–44.PubMed

18.

Girdlestone GR. The pathology and treatment of tuberculosis of the knee-joint. Br J Surg. 1932;19:488–507.CrossRef

19.

Hand WL, King-Thompson NL, Steinberg TH. Interactions of antibiotics and phagocytes. J Antimicrob Chemother. 1983;12(suppl C):1–11.PubMedCrossRef

20.

Harris HW. Current concepts of the metabolism of antituberculous agents. Ann N Y Acad Sci. 1963;106:43–47.PubMedCrossRef

21.

Hibbs RA. The treatment of tuberculosis of the joints of the lower extremities by operative fusion. J Bone Joint Surg Am. 1930;12:749–754.

22.

Jenkin G. Isoniazid. In: Grayson ML, Kucers A, Crowe S, McCarthy J, Mills J, eds. Kucers’ The Use ofAantibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic and Antiviral drugs. Ed 6. London, UK: Hodder Arnold; 2010:1549–1553.

23.

Key JA. Positive pressure in arthrodesis for tuberculosis of the knee joint. 1932. Clin Orthop Relat Res. 2007;461:6–8.PubMedCrossRef

24.

Laine JC, Nguyen TQ, Buckley JM, Kim HT. Effects of mixing techniques on vancomycin-impregnated polymethylmethacrylate. J Arthroplasty. 2011;26:1562–1566.PubMedCrossRef

25.

Lange CG, Getty PJ, Morrissey AB, George AL, Young PC, Armitage KB. Destructive osteoarthritis after delayed diagnosis of tuberculosis. Infection. 2002;30:46–49.PubMedCrossRef

26.

Leclere LE, Sechriest VF 2nd, Holley KG, Tsukayama DT. Tuberculous arthritis of the knee treated with two-stage total knee arthroplasty: a case report. J Bone Joint Surg Am. 2009;91:186–191.PubMedCrossRef

27.

Martini M, Ouahes M. Bone and joint tuberculosis: a review of 652 cases. Orthopedics. 1988;11:861–866.PubMed

28.

Masri BA, Duncan CP, Jewesson P, Ngui-Yen J, Smith J. Streptomycin-loaded bone cement in the treatment of tuberculous osteomyelitis: an adjunct to conventional therapy. Can J Surg. 1995;38:64–68.PubMed

29.

Milovanova EM, Kovalenko KN. [Surgical correction of skeletal deformations in children with osteoarticular tuberculosis][in Russian]. Vestn Khir Im I I Grek. 1979;122:68–73.PubMed

30.

Mitchison DA. Clinical development of anti-tuberculosis drugs. J Antimicrob Chemother. 2006;58:494–495.PubMedCrossRef

31.

Mittal R, Trikha V, Rastogi S. Tuberculosis of patella. Knee. 2006;13:54–56.PubMedCrossRef

32.

Muradali D, Gold WL, Vellend H, Becker E. Multifocal osteoarticular tuberculosis: report of four cases and review of management. Clin Infect Dis. 1993;17:204–209.PubMedCrossRef

33.

Netval M, Hudec T, Hach J. [Our experience with total knee arthroplasty following tuberculous arthritis (1980–2005)][in Czech]. Acta Chir Orthop Traumatol Cech. 2007;74:111–113.PubMed

34.

Nuermberger E, Grosset J. Pharmacokinetic and pharmacodynamic issues in the treatment of mycobacterial infections. Eur J Clin Microbiol Infect Dis. 2004;23:243–255.PubMedCrossRef

35.

Pointud P, Prudat M, Laluque S, Amouroux J. [Tuberculous arthritis and chondrocalcinosis: apropos of 2 cases][in French]. Rev Rhum Ed Fr. 1993;60:617–620.PubMed

36.

Robson JM, Sullivan FM. Antituberculosis drugs. Pharmacol Rev. 1963;15:169–223.PubMed

37.

Senn N. Tuberculosis of Bones and Joints. Philadelphia, PA: FA Davis; 1893.

38.

Shikhare SN, Singh DR, Shimpi TR, Peh WC. Tuberculous osteomyelitis and spondylodiscitis. Semin Musculoskelet Radiol. 2011;15:446–458.PubMedCrossRef

39.

Su JY, Huang TL, Lin SY. Total knee arthroplasty in tuberculous arthritis. Clin Orthop Relat Res. 1996;323:181–187.PubMedCrossRef

40.

Titov AG, Nakonechniy GD, Santavirta S, Serdobintzev MS, Mazurenko SI, Konttinen YT. Arthroscopic operations in joint tuberculosis. Knee. 2004;11:57–62.PubMedCrossRef

41.

van Loenhout-Rooyackers JH, Verbeek AL, Jutte PC. Chemotherapeutic treatment for spinal tuberculosis. Int J Tuberc Lung Dis. 2002;6:259–265.PubMed

42.

Watts HG, Lifeso RM. Tuberculosis of bones and joints. J Bone Joint Surg Am. 1996;78:288–298.PubMed

43.

Weiner M, Burman W, Vernon A, Benator D, Peloquin CA, Khan A, Weis S, King B, Shah N, Hodge T. Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine. Am J Respir Crit Care Med. 2003;167:1341–1347.PubMedCrossRef

44.

WHO. Stop TB Annual Report 2001. Geneva, Switzerland: World Health Organization; 2002. Available at: http://www.stoptb.org/assets/documents/resources/publications/annualreports/Final_report2001.pdf. Accessed January 25, 2013.

45.

WHO. Tuberculosis Fact sheet No 104. Geneva, Switzerland: World Health Organization; 2010. Available at: http://www.who.int/mediacentre/factsheets/fs104/en/index.html. Accessed January 25, 2013.

46.

Wilkinson MC. Synovectomy and curettage in the treatment of tuberculosis of joints. J Bone Joint Surg Br. 1953;35:209–223.PubMed

47.

Wolfgang GL. Tuberculosis joint infection. Clin Orthop Relat Res. 1978;136:257–263.PubMed

Titel: Isoniazid Could Be Used for Antibiotic-loaded Bone Cement for Musculoskeletal Tuberculosis: An In Vitro Study
verfasst von: Chang Dong Han, MD, PhD
Taegwon Oh, RPH, PhD
Sang-Nae Cho, DVM, PhD
Jae Ho Yang, MD
Kwan Kyu Park, MD, PhD
Publikationsdatum: 01.07.2013
Verlag: Springer-Verlag
Erschienen in: Clinical Orthopaedics and Related Research® / Ausgabe 7/2013
Print ISSN: 0009-921X
Elektronische ISSN: 1528-1132
DOI: https://doi.org/10.1007/s11999-013-2899-5

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen.
» Jetzt entdecken

Neu im Fachgebiet Orthopädie und Unfallchirurgie

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders scheint das auf weibliche Kranke zuzutreffen, wie eine Studie zeigt.

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Isoniazid Could Be Used for Antibiotic-loaded Bone Cement for Musculoskeletal Tuberculosis: An In Vitro Study